|
Second patient gets artificial heart
By Rhonda Rowland LOUISVILLE, Kentucky (CNN) -- The second self-contained artificial heart was implanted in a 70-year-old man at Jewish Hospital Thursday. The hospital identified him as Tom Christerson of Central City, Kentucky. The operation was performed by the same surgical team that implanted the world's first artificial heart in Robert Tools July 2. Drs. Laman Gray and Rob Dowling said the second patient was recovering in the intensive care unit and resting comfortably. Robert Tools has continued to improve and was moved out of the intensive care unit last week. The AbioCor artificial heart, manufactured by Abiomed Inc., fits inside the body and is battery-operated. The Food and Drug Administration gave the company approval to implant the device in five patients in initial studies. Depending on how the first patients do, the study may expand to include a total of 15 patients. Patients considered for the studies must have advanced heart failure and not be candidates for other treatments including heart transplantation. Like Tools, patients must have only a 20 percent chance of surviving a month without the device. Doctors say Tools has exceeded expectations, already surviving more than two months with his artificial heart. |
|
||||||||||||||||||||
|
RELATED STORIES:
Doctor: 'Thrilled' for heart recipient
August 21, 2001 Heart patient had to 'take chance' August 22, 2001 RELATED SITES:
The Implantable Artificial Heart Project
Jewish Hospital Abiomed: Focus on the Heart Note: Pages will open in a new browser window
External sites are not endorsed by CNN Interactive.
HEALTH TOP STORIES:
Clearing up picture on laser eye surgery No serious smallpox shot reactions yet Iraqi children vaccinated for polio Survey seeks to ID depressed teens FTC shuts down firm touting cancer cure (More) |
||||||||||||||||||||||
| Back to the top |
© 2003 Cable News Network LP, LLLP.
A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Read our privacy guidelines. Contact us. |